CONMED CORPORATION Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
CONMED CORPORATION (CNMD) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt of $39.15 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-22.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt · last filed 2022-02-22
- CONMED CORPORATION adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2019-03-31 was $39.15M.
- CONMED CORPORATION adjustments to additional paid in capital, equity component of convertible debt for fiscal 2019 was $39.15M.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 3 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 12 month |
|---|---|---|
| 2019-12-31 | $39.15M 10-K · filed 2022-02-22 | |
| 2019-03-31 | $39.15M 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |